The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease
Open accessAbstract
We report the evidence-based Italian Association for the Study of Liver guidelines for the appropriate diagnosis and management of patients with nonalcoholic fatty liver disease in clinical practice and its related research agenda. The prevalence of nonalcoholic fatty liver disease varies according to age, gender and ethnicity. In the general population, the prevalence of nonalcoholic fatty liver disease is about 25% and the incidence is of two new cases/100 people/year. 2-3% of individuals in the general population will suffer from nonalcoholic steatohepatitis. Uncomplicated steatosis will usually follow a benign course. Individuals with nonalcoholic steatohepatitis, however, have a reduced life expectancy, mainly owing to vascular diseases and liver-related causes. Moreover, steatosis has deleterious effects on the natural history of HCV infection. Nonalcoholic fatty liver disease is usually diagnosed in asymptomatic patients prompted by the occasional discovery of increased liver enzymes and/or of ultrasonographic steatosis. Medical history, complete physical examination, etiologic screening of liver injury, liver biochemistry tests, serum lipids and insulin sensitivity tests should be performed in every patient. Occult alcohol abuse should be ruled out. Ultrasonography is the first-line imaging technique. Liver biopsy, the gold standard in diagnosis and prognosis of nonalcoholic fatty liver disease, is an invasive procedure and its results will not influence treatment in most cases but will provide prognostic information. Assessment of fibrosis by composite scores, specific laboratory parameters and transient elastography might reduce the number of nonalcoholic fatty liver disease patients requiring liver biopsy. Dieting and physical training reinforced by behavioural therapy are associated with improved nonalcoholic fatty liver disease. Diabetes and the metabolic syndrome should be ruled out at timed intervals in nonalcoholic fatty liver disease. Nonalcoholic steatohepatitis patients should undergo periodic evaluation of cardiovascular risk and of advancement of their liver disease; those with nonalcoholic steatohepatitis-cirrhosis should be evaluated for early diagnosis of hepatocellular carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Biomarkers of alcoholism: an updated review
Das, S. K., Dhanya, L., & Vasudevan, D. M. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701532662 · Cited by 55
RetractedDesign and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
Self-citationThe Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
The utility of radiological imaging in nonalcoholic fatty liver disease
Saadeh, S., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,110
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106
Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C., & Smith, A. D. (2009) · Hepatology · doi:10.1002/hep.22742 · Cited by 1,997
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis
Friedrich–Rust, M., Ong, M., Martens, S., Sarrazin, C., Bojunga, J., Zeuzem, S., & Herrmann, E. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.034 · Cited by 1,490
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Updated definitions of healthy ranges for serum alanine aminotransferase levels
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445
Self-citationBugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Carucci, P., Musso, A., De Paolis, P., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,439
Self-citationDixon, J. B., Bhathal, P. S., & O'Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,360
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263
Self-citationMofrad, P., Contos, M. J., Haque, M., Sargeant, C., Fisher, R. A., Luketic, V. A., Sterling, R. K., Shiffman, M. L., Stravitz, R. T., & Sanyal, A. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50229 · Cited by 1,201
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations
Castéra, L., Foucher, J., Bernard, P.-H., Carvalho, F., Allaix, D., Merrouche, W., Couzigou, P., & de Lédinghen, V. (2010) · Hepatology · doi:10.1002/hep.23425 · Cited by 1,159
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Hamaguchi, M., Kojima, T., Takeda, N., Nakagawa, T., Taniguchi, H., Fujii, K., Omatsu, T., Nakajima, T., Sarui, H., Shimazaki, M., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-10-200511150-00009 · Cited by 1,062
Adinolfi, L. E., Gambardella, M., Andreana, A., Tripodi, M.-F., Utili, R., & Ruggiero, G. (2001) · Hepatology · doi:10.1053/jhep.2001.24432 · Cited by 1,059
Self-citationLiver fibrosis in overweight patients
Ratziu, V., Giral, P., Charlotte, F., Bruckert, E., Thibault, V., Theodorou, I., Khalil, L., Turpin, G., Opolon, P., & Poynard, T. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70364-7 · Cited by 973
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 925
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Self-citationNonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870
Harrison, S. A., Oliver, D., Arnold, H. L., Gogia, S., & Neuschwander-Tetri, B. A. (2008) · Gut · doi:10.1136/gut.2007.146019 · Cited by 869
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 863
Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
Kotronen, A., Peltonen, M., Hakkarainen, A., Sevastianova, K., Bergholm, R., Johansson, L. M., Lundbom, N., Rissanen, A., Ridderstråle, M., Groop, L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.005 · Cited by 804
Musso, G., Gambino, R., De Michieli, F., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., & Pagano, G. (2003) · Hepatology · doi:10.1053/jhep.2003.50132 · Cited by 759
Guha, I. N., Parkes, J., Roderick, P., Chattopadhyay, D., Cross, R., Harris, S., Kaye, P., Burt, A. D., Ryder, S. D., Aithal, G. P., et al. (2008) · Hepatology · doi:10.1002/hep.21984 · Cited by 745
The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective
Lazo, M., & Clark, J. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091978 · Cited by 736
Romero-Gómez, M., Del Mar Viloria, M., Andrade, R. J., Salmerón, J., Diago, M., Fernández-Rodríguez, C. M., Corpas, R., Cruz, M., Grande, L., Vázquez, L., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.049 · Cited by 732
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
Rafiq, N., Bai, C., Fang, Y., Srishord, M., McCullough, A., Gramlich, T., & Younossi, Z. M. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.11.005 · Cited by 729
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial
Lindor, K. D., Kowdley, K. V., Heathcote, J. E., Harrison, E. M., Jorgensen, R., Angulo, P., Lymp, J. F., Burgart, L., & Colin, P. (2004) · Hepatology · doi:10.1002/hep.20092 · Cited by 727 · cited 2×
“[145] Lindor KD, Kowdley KV, Heathcote EJ, et al.”
BackgroundFracanzani, A. L., Valenti, L., Bugianesi, E., Andreoletti, M., Colli, A., Vanni, E., Bertelli, C., Fatta, E., Bignamini, D., Marchesini, G., et al. (2008) · Hepatology · doi:10.1002/hep.22429 · Cited by 711
Self-citationRecent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
MUSSO, G., GAMBINO, R., & CASSADER, M. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.08.001 · Cited by 681
Excess weight risk factor for alcoholic liver disease
Naveau, S., Giraud, V., Borotto, E., Aubert, A., Capron, F., & Chaput, J. (1997) · Hepatology · doi:10.1002/hep.510250120 · Cited by 666 · cited 2×
“Level of evidence: III–IV Strength of recommendation: A Obese subjects are likely to be exposed to more severe alcohol epatotoxicity [113,114].”
BackgroundValidity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study
Dasarathy, S., Dasarathy, J., Khiyami, A., Joseph, R., Lopez, R., & McCullough, A. J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.09.001 · Cited by 656
Bolondi, L., Sofia, S., Siringo, S., Gaiani, S., Casali, A., Zironi, G., Piscaglia, F., Gramantieri, L., Zanetti, M., & Sherman, M. (2001) · Gut · doi:10.1136/gut.48.2.251 · Cited by 643
Drinking habits as cofactors of risk for alcohol induced liver damage
Bellentani, S., Saccoccio, G., Costa, G., Tiribelli, C., Manenti, F., Sodde, M., Croce’, L. S., Sasso, F., Pozzato, G., Cristianini, G., et al. (1997) · Gut · doi:10.1136/gut.41.6.845 · Cited by 630 · cited 4×
“[107] Bellentani S, Saccoccio G, Costa G, et al.”
BackgroundInfluentialSelf-citationPoynard, T., Ratziu, V., McHutchison, J., Manns, M., Goodman, Z., Zeuzem, S., Younossi, Z., & Albrecht, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50267 · Cited by 604
Non-alcoholic fatty liver disease: The mist gradually clears
de Alwis, N. M. W., & Day, C. P. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.009 · Cited by 603
Sangiovanni, A., Del Ninno, E., Fasani, P., De Fazio, C., Ronchi, G., Romeo, R., Morabito, A., de Franchis, R., & Colombo, M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.049 · Cited by 600
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3
Rubbia-Brandt, L., Quadri, R., Abid, K., Giostra, E., Malé, P.-J., Mentha, G., Spahr, L., Zarski, J.-P., Borisch, B., Hadengue, A., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80166-x · Cited by 593
Laurin, J., Lindor, K. D., Crippin, J. S., Gossard, A., Gores, G. J., Ludwig, J., Rakela, J., & McGill, D. B. (1996) · Hepatology · doi:10.1002/hep.510230624 · Cited by 566
Leandro, G., Mangia, A., Hui, J., Fabris, P., Rubbia–Brandt, L., Colloredo, G., Adinolfi, L. E., Asselah, T., Jonsson, J. R., Smedile, A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.014 · Cited by 565
Self-citationVuppalanchi, R., & Chalasani, N. (2009) · Hepatology · doi:10.1002/hep.22603 · Cited by 563
Zelber-Sagi, S., Nitzan-Kaluski, D., Goldsmith, R., Webb, M., Blendis, L., Halpern, Z., & Oren, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.020 · Cited by 551
Farrell, G. C., Chitturi, S., Lau, G. K., Sollano, J. D., & NAFLD, F. T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05002.x · Cited by 517
Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis
Mummadi, R. R., Kasturi, K. S., Chennareddygari, S., & Sood, G. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.012 · Cited by 511
Long term prognosis of fatty liver: risk of chronic liver disease and death
Dam-Larsen, S., Franzmann, M., Andersen, I. B., Christoffersen, P., Jensen, L. B., Sørensen, T. I. A., Becker, U., & Bendtsen, F. (2004) · Gut · doi:10.1136/gut.2003.019984 · Cited by 508
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
Harrison, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00622-1 · Cited by 482
Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease
Jou, J., Choi, S., & Diehl, A. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091981 · Cited by 482
Interobserver and Intraobserver Variability in the Sonographic Assessment of Fatty Liver
Strauss, S., Gavish, E., Gottlieb, P., & Katsnelson, L. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.07.2123 · Cited by 478
Natural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies
Fassio, E., �lvarez, E., Dom�nguez, N., Landeira, G., & Longo, C. (2004) · Hepatology · doi:10.1002/hep.20410 · Cited by 469
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis
Ratziu, V., Bonyhay, L., Di Martino, V., Charlotte, F., Cavallaro, L., Sayegh-Tainturier, M.-H., Giral, P., Grimaldi, A., Opolon, P., & Poynard, T. (2002) · Hepatology · doi:10.1053/jhep.2002.33324 · Cited by 464
Yokohama, S., Yoneda, M., Haneda, M., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Tokusashi, Y., Miyokawa, N., & Nakamura, K. (2004) · Hepatology · doi:10.1002/hep.20420 · Cited by 458
Long–Term Outcomes of Cirrhosis in Nonalcoholic Steatohepatitis Compared With Hepatitis C
Hui, J. M., Kench, J. G., Chitturi, S., Sud, A., Farrell, G. C., Byth, K., Hall, P., Khan, M., & George, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50320 · Cited by 437
Yoneda, M., Yoneda, M., Mawatari, H., Fujita, K., Endo, H., Iida, H., Nozaki, Y., Yonemitsu, K., Higurashi, T., Takahashi, H., et al. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.10.019 · Cited by 428
Adams, L. A., Waters, O. R., Knuiman, M. W., Elliott, R. R., & Olynyk, J. K. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.67 · Cited by 413
Sookoian, S., & Pirola, C. J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.012 · Cited by 406
Gastaldelli, A., Kozakova, M., Hφjlund, K., Flyvbjerg, A., Favuzzi, A., Mitrakou, A., & Balkau, B. (2009) · Hepatology · doi:10.1002/hep.22845 · Cited by 377
Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C
Fartoux, L., Poujol-Robert, A., Guéchot, J., Wendum, D., Poupon, R., & Serfaty, L. (2005) · Gut · doi:10.1136/gut.2004.050302 · Cited by 375
GI Epidemiology: nonalcoholic fatty liver disease
ANGULO, P. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03246.x · Cited by 369
Lê, K.-A., Ith, M., Kreis, R., Faeh, D., Bortolotti, M., Tran, C., Boesch, C., & Tappy, L. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27336 · Cited by 369
Ratziu, V., Charlotte, F., Bernhardt, C., Giral, P., Halbron, M., LeNaour, G., Hartmann-Heurtier, A., Bruckert, E., & Poynard, T. (2010) · Hepatology · doi:10.1002/hep.23270 · Cited by 366
Dufour, J., Oneta, C. M., Gonvers, J., Bihl, F., Cerny, A., Cereda, J., Zala, J., Helbling, B., Steuerwald, M., & Zimmermann, A. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.025 · Cited by 358
Bressler, B. L., Guindi, M., Tomlinson, G., & Heathcote, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50350 · Cited by 358
PALMENTIERI, B., DESIO, I., LAMURA, V, MASARONE, M., VECCHIONE, R., BRUNO, S., TORELLA, R., & PERSICO, M. (2006) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.03.021 · Cited by 341
Self-citationMathiesen, U. L., Franzen, L. E., Åselius, H., Resjö, M., Jacobsson, L., Foberg, U., Frydén, A., & Bodemar, G. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80111-6 · Cited by 340
Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
Dunn, W., Xu, R., Wingard, D. L., Rogers, C., Angulo, P., Younossi, Z. M., & Schwimmer, J. B. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02034.x · Cited by 325
Ohata, K., Hamasaki, K., Toriyama, K., Matsumoto, K., Saeki, A., Yanagi, K., Abiru, S., Nakagawa, Y., Shigeno, M., Miyazoe, S., et al. (2003) · Cancer · doi:10.1002/cncr.11427 · Cited by 322
Independent effects of physical activity in patients with nonalcoholic fatty liver disease #
St. George, A., Bauman, A., Johnston, A., Farrell, G., Chey, T., & George, J. (2009) · Hepatology · doi:10.1002/hep.22940 · Cited by 318
Castéra, L., Hézode, C., Roudot-Thoraval, F., Bastie, A., Zafrani, E.-S., Pawlotsky, J.-M., & Dhumeaux, D. (2003) · Gut · doi:10.1136/gut.52.2.288 · Cited by 298
Bariatric surgery for non-alcoholic steatohepatitis in obese patients
Chavez-Tapia, N. C., Tellez-Avila, F. I., Barrientos-Gutierrez, T., Mendez-Sanchez, N., Lizardi-Cervera, J., & Uribe, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007340.pub2 · Cited by 297
Valenti, L., Fracanzani, A. L., Dongiovanni, P., Bugianesi, E., Marchesini, G., Manzini, P., Vanni, E., & Fargion, S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01192.x · Cited by 290
Self-citationSoft drink consumption is associated with fatty liver disease independent of metabolic syndrome
Abid, A., Taha, O., Nseir, W., Farah, R., Grosovski, M., & Assy, N. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.033 · Cited by 287
Westin, J., Nordlinder, H., Lagging, M., Norkrans, G., & Wejstål, R. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00299-4 · Cited by 280
Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)
Yoneda, M., Fujita, K., Inamori, M., Nakajima, A., Tamano, M., & Hiraishi, H. (2007) · Gut · doi:10.1136/gut.2007.126417 · Cited by 278
Niemelä, O. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.08.035 · Cited by 262
Helmerhorst, H. J. F., Wijndaele, K., Brage, S., Wareham, N. J., & Ekelund, U. (2009) · Diabetes · doi:10.2337/db08-1773 · Cited by 258
Non-invasive means of measuring hepatic fat content
Mehta, S. R., Thomas, E. L., Bell, J. D., Johnston, D. G., & Taylor-Robinson, S. D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3476 · Cited by 255
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis†
Lutchman, G., Modi, A., Kleiner, D. E., Promrat, K., Heller, T., Ghany, M., Borg, B., Loomba, R., Liang, T. J., Premkumar, A., et al. (2007) · Hepatology · doi:10.1002/hep.21661 · Cited by 244
Ruhl, C. E., & Everhart, J. E. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00743-3 · Cited by 242
Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach
Bellentani, S., Dalle Grave, R., Suppini, A., & Marchesini, G. (2008) · Hepatology · doi:10.1002/hep.22009 · Cited by 237
Self-citationPathology of fatty liver disease
Brunt, E. M. (2007) · Modern Pathology · doi:10.1038/modpathol.3800680 · Cited by 237
Incidence and natural course of fatty liver in the general population: The Dionysos study
Bedogni, G., Miglioli, L., Masutti, F., Castiglione, A., Crocè, L. S., Tiribelli, C., & Bellentani, S. (2007) · Hepatology · doi:10.1002/hep.21827 · Cited by 226
Self-citationModest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease
Dunn, W., Xu, R., & Schwimmer, J. B. (2008) · Hepatology · doi:10.1002/hep.22292 · Cited by 213
D'Souza, R., Sabin, C. A., & Foster, G. R. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41403.x · Cited by 212
Setji, T. L., Holland, N. D., Sanders, L. L., Pereira, K. C., Diehl, A. M., & Brown, A. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2774 · Cited by 210
Baumeister, S. E., Völzke, H., Marschall, P., John, U., Schmidt, C., Flessa, S., & Alte, D. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.024 · Cited by 208
Biochemical markers of alcoholism
Hannuksela, M. L., Liisanantti, M. K., Nissinen, A. E. T., & Savolainen, M. J. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.190 · Cited by 196
(2002) · Gastroenterology · doi:10.1053/gast.2002.36569 · Cited by 193
Pekow, J. R., Bhan, A. K., Zheng, H., & Chung, R. T. (2007) · Cancer · doi:10.1002/cncr.22701 · Cited by 185
Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography
Pinzani, M., Vizzutti, F., Arena, U., & Marra, F. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1025 · Cited by 178
Self-citationRace, insulin resistance and hepatic steatosis in chronic hepatitis C
Conjeevaram, H. S., Kleiner, D. E., Everhart, J. E., Hoofnagle, J. H., Zacks, S., Afdhal, N. H., & Wahed, A. S. (2007) · Hepatology · doi:10.1002/hep.21455 · Cited by 176
Natural History of NAFLD: Remarkably Benign in the Absence of Cirrhosis
Day, C. P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.041 · Cited by 176
A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients
Campos, G. M., Bambha, K., Vittinghoff, E., Rabl, C., Posselt, A. M., Ciovica, R., Tiwari, U., Ferrel, L., Pabst, M., Bass, N. M., et al. (2008) · Hepatology · doi:10.1002/hep.22241 · Cited by 172
[Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases].
(2006) · PubMed · Cited by 167
When is steatosis too much for transplantation?
Nocito, A., El-Badry, A. M., & Clavien, P.-A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.07.017 · Cited by 164
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Arcaro, G., & Day, C. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.021 · Cited by 162
Insulin resistance, iron, and the liver
Ferrannini, E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02397-7 · Cited by 161
Satapathy, S. K., Sakhuja, P., Malhotra, V., Sharma, B. C., & Sarin, S. K. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04756.x · Cited by 160
Wong, G. L., Wong, V. W., Choi, P. C., Chan, A. W., Chum, R. H., Chan, H. K., Lau, K. K., Chim, A. M., Yiu, K. K., Chan, F. K., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.038 · Cited by 160
Hepatitis C and steatosis: a reappraisal
Lonardo, A., Loria, P., Adinolfi, L. E., Carulli, N., & Ruggiero, G. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00669.x · Cited by 156
Self-citationAlcohol Consumption by Aging Adults in the United States: Health Benefits and Detriments
Ferreira, M. P., & Weems, M. K. S. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.07.011 · Cited by 151
Endocrine and liver interaction: the role of endocrine pathways in NASH
Loria, P., Carulli, L., Bertolotti, M., & Lonardo, A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.33 · Cited by 150
Self-citationHealth‐related fitness and physical activity in patients with nonalcoholic fatty liver disease†‡
Krasnoff, J. B., Painter, P. L., Wallace, J. P., Bass, N. M., & Merriman, R. B. (2008) · Hepatology · doi:10.1002/hep.22137 · Cited by 148
‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis
Lonardo, A., Carani, C., Carulli, N., & Loria, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.03.005 · Cited by 145
Self-citationHock, B., Schwarz, M., Domke, I., Grunert, V. P., Wuertemberger, M., Schiemann, U., Horster, S., Limmer, C., Stecker, G., & Soyka, M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01216.x · Cited by 138
Diabetes duration and cause-specific mortality in the Verona Diabetes Study.
Brun, E., Nelson, R. G., Bennett, P. H., Imperatore, G., Zoppini, G., Verlato, G., Muggeo, M., & Study, V. D. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1119 · Cited by 135
Charlton, M., Angulo, P., Chalasani, N., Merriman, R., Viker, K., Charatcharoenwitthaya, P., Sanderson, S. O., Gawrieh, S., Krishnan, A., & Lindor, K. D. (2008) · Hepatology · doi:10.1002/hep.22063 · Cited by 125
Risk of Cancer in Patients Hospitalized With Fatty Liver
Sørensen, H. T., Mellemkjær, L., Jepsen, P., Thulstrup, A. M., Baron, J. A., Olsen, J. H., & Vilstrup, H. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200304000-00015 · Cited by 119
The evolving role of liver biopsy
Campbell, M. S., & Reddy, K. R. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02071.x · Cited by 118
Gunji, T., Matsuhashi, N., Satō, H., Fujibayashi, K., Okumura, M., Sasabe, N., & Urabe, A. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.361 · Cited by 113
Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease
Roldán-Valadéz, E., Favila, R., Martínez-López, M., Uribe, M., & Méndez‐Sánchez, N. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31850-2 · Cited by 113
Calle, E. E. (2007) · BMJ · doi:10.1136/bmj.39384.472072.80 · Cited by 107
High prevalence of metabolic complications in patients with non‐alcoholic fatty liver disease
Friis–Liby, I., Aldenborg, F., Jerlstad, P., Rundström, K., & Bjornsson, E. S. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410006431 · Cited by 103
Harrison, S. A., Brunt, E. M., Qazi, R. A., Oliver, D. A., Neuschwander‐Tetri, B. A., DIBISCEGLIE, A., & Bacon, B. R. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00246-6 · Cited by 103
Ryan, M. C., Abbasi, F., Lamendola, C. A., Carter, S., & McLaughlin, T. (2007) · Diabetes Care · doi:10.2337/dc06-2169 · Cited by 100
Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence?
Yu, A. S., & Keeffe, E. B. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07485.x · Cited by 93
Loguercio, C., Simone, T. D., D’Auria, M. V., de Sio, I., Federico, A., Tuccillo, C., Abbatecola, A. M., & Blanco, C. D. V. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.01.022 · Cited by 92
Self-citationComputed Tomography Features of Nonalcoholic Steatohepatitis With Histopathologic Correlation
Oliva, M. R., Mortelé, K. J., Segatto, E., Glickman, J. N., Ertürk, Ş. M., Ros, P. R., & Silverman, S. G. (2005) · Journal of Computer Assisted Tomography · doi:10.1097/01.rct.0000193818.31749.84 · Cited by 92
Should Nonalcoholic Fatty Liver Disease Be Renamed?
Loria, P., Lonardo, A., & Carulli, N. (2005) · Digestive Diseases · doi:10.1159/000084728 · Cited by 83
Self-citationNon-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question
Loria, P., Lonardo, A., Bellentani, S., Day, C., Marchesini, G., & Carulli, N. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.007 · Cited by 77
Self-citationTanaka, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i39.5180 · Cited by 76
Svegliati‐Baroni, G., Bugianesi, E., Bouserhal, T., Marini, F., Ridolfi, F., Tarsetti, F., Ancarani, F., Petrelli, E., Peruzzi, E., Cascio, M. L., et al. (2007) · Gut · doi:10.1136/gut.2006.107946 · Cited by 76
Self-citationLee, H., Choi, E., & Pak, C. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609788897844 · Cited by 76
Effect of a dietary-induced weight loss on liver enzymes in obese subjects
Gasteyger, C., Larsen, T. M., Vercruysse, F., & Astrup, A. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1141 · Cited by 75
Tsochatzis, E. A., Papatheodoridis, G., Manesis, E. K., Kafiri, G., TINIAKOS, D. G., & Archimandritis, A. J. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03538.x · Cited by 74
Tsochatzis, E. A., Papatheodoridis, G., Manesis, E. K., Kafiri, G., & Archimandritis, A. J. (2007) · Journal of Hepatology · doi:10.1016/s0168-8278(07)62365-4 · Cited by 73
Light to Moderate Alcohol Consumption Is Associated With Lower Frequency of Hypertransaminasemia
Suzuki, A., Angulo, P., Sauver, J. L. S., Muto, A., Okada, T., & Lindor, K. D. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01274.x · Cited by 70
Determination of biological markers for alcohol abuse
Mußhoff, F., & Daldrup, T. (1998) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00503-3 · Cited by 68
Genes and nonalcoholic fatty liver disease
de Alwis, N. M. W., & Day, C. P. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0027-9 · Cited by 64
Lifestyle Modification as the Primary Treatment of NASH
Neuschwander‐Tetri, B. A. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.006 · Cited by 63
Adinolfi, L. E., Durante‐Mangoni, E., Zampino, R., & Ruggiero, G. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02597.x · Cited by 57
Self-citationThe impact of hepatic steatosis on the natural history of chronic hepatitis C infection
Cross, T. J. S., Quaglia, A., Hughes, S., Joshi, D., & Harrison, P. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01098.x · Cited by 50
Zeuzem, S., Alberti, A., Rosenberg, W. M., Marcellin, P., Diago, M., Negro, F., Prati, D., Puoti, C., Roberts, S., & Shiffman, M. L. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03073.x · Cited by 47
Self-citationEVALUATION OF TWO BIOLOGICAL MARKERS COMBINED AS A PARAMETER OF ALCOHOL DEPENDENCY
Huseby, N. E., Nilssen, O., & KANITZ, R.-D. (1997) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008323 · Cited by 38
Lonardo, A., Ballestri, S., Adinolfi, L. E., Violi, E., Carulli, L., Lombardini, S., Scaglioni, F., Ricchi, M., Ruggiero, G., & Loria, P. (2009) · Canadian Journal of Gastroenterology · doi:10.1155/2009/369703 · Cited by 31
Self-citationTakuma, Y., Nouso, K., Makino, Y., Saito, S., Takayama, H., Takahara, M., Takahashi, H., Murakami, I., & TAKEUCHI, H. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01462.x · Cited by 23
Corrao, G., Zambon, A., Bagnardi, V., Aricò, S., Loguercio, C., & D’Amicis, A. (2004) · European Journal of Epidemiology · doi:10.1023/b:ejep.0000040534.89451.d2 · Cited by 18
Self-citationNeff, L. M., & Aronne, L. J. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0061-0 · Cited by 17
Type 2 diabetes, thiazolidinediones, and cardiovascular risk
Taylor, C. J., & Hobbs, R. F. (2009) · British Journal of General Practice · doi:10.3399/bjgp09x453440 · Cited by 17
Propensity for non‐alcoholic fatty liver disease: more evidence for ethnic susceptibility
Harmon, R. C., & Caldwell, S. H. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01959.x · Cited by 8
Cited by
Loomba, R., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,641
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., & Loria, P. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.09.020 · Cited by 685
Self-citationThoma, C., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.06.010 · Cited by 523
Vajro, P., Lenta, S., Socha, P., Dhawan, A., McKiernan, P., Baumann, U., Durmaz, O., Lacaille, F., McLin, V., & Nobili, V. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318252a13f · Cited by 528
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Lonardo, A., Bellentani, S., Argo, C. K., Ballestri, S., Byrne, C. D., Caldwell, S. H., Cortez-Pinto, H., Grieco, A., Machado, M. V., Miele, L., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.004 · Cited by 444
Self-citation
Metadata
- Authors
- Loria, P., Adinolfi, L. E., Bellentani, S., Bugianesi, E., Grieco, A., Fargion, S., Gasbarrini, A., Loguercio, C., Lonardo, A., Marchesini, G., Marra, F., Persico, M., Prati, D., & Baroni, G. S.
- Venue
- Digestive and Liver Disease
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 42
- Issue
- 4
- Pages
- 272-282
- ISSN
- 1590-8658 (ISSN-L)
- OpenAlex
- W155379592
- Cited by
- 294
- References
- 152
- FWCI
- 15.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.